Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Active Systemic Lupus Erythematosus”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT01753401
What this trial is testing

Acthar for the Treatment of Systemic Lupus Erythematosus (SLE) in Patients With a History of Persistently Active Disease

Who this might be right for
Systemic Lupus Erythematosus (SLE)
Mallinckrodt 38
Post-approval studies (Phase 4)Study completedNCT00371319
What this trial is testing

Comparing the Efficacy of Tacrolimus and Mycophenolate Mofetil for the Initial Therapy of Active Lupus Nephritis

Who this might be right for
Lupus Nephritis
Tuen Mun Hospital 150
Not applicableStudy completedNCT01904812
What this trial is testing

Longitudinal Study of Quality of Life and Activity in Systemic Lupus Erythematosus

Who this might be right for
Lupus Erythematosus
Centre Hospitalier Universitaire Dijon 356
Early research (Phase 1)UnknownNCT06297408
What this trial is testing

Relma-cel for Moderate to Severe Active Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Shanghai Ming Ju Biotechnology Co., Ltd. 24
Not applicableLooking for participantsNCT03138941
What this trial is testing

Validation of the Lupus Low Disease Activity State (LLDAS) in the Asia Pacific Region

Who this might be right for
Systemic Lupus Erythematosus
Monash University 5,000
Large-scale testing (Phase 3)Looking for participantsNCT06406205
What this trial is testing

QLG1074 Combined With Background Therapy in Subjects With Active Lupus Nephritis

Who this might be right for
Lupus Nephritis
Qilu Pharmaceutical Co., Ltd. 270
Testing effectiveness (Phase 2)Study completedNCT01559090
What this trial is testing

Safety and Tolerability of Intravenous Dose of MEDI-546 in Japanese Subjects With Systemic Lupus Erythematosus.

Who this might be right for
Systemic Lupus Erythematosus
AstraZeneca 17
Very early researchTemporarily pausedNCT06549296
What this trial is testing

Clinical Study on Targeted CD19CAR-T Therapy for Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusSystemic SclerosisANCA Associated Vasculitis+3 more
Nanjing Bioheng Biotech Co., Ltd. 12
Testing effectiveness (Phase 2)Ended earlyNCT02677688
What this trial is testing

Autologous EBV-specific Cytotoxic T Cells for the Treatment of Systemic Lupus Erythematosus (SLE)

Who this might be right for
Serologically Active Adult Systemic Lupus Erythematosus
Nantes University Hospital 9
Not applicableNot Yet RecruitingNCT06999109
What this trial is testing

Teams Engaged in Accessible Mental Health Interventions for Lupus Erythematosus and Dermatomyositis Stress

Who this might be right for
LupusDermatomyositis, JuvenileDermatomyositis+3 more
Duke University 25
Testing effectiveness (Phase 2)Study completedNCT00660881
What this trial is testing

Open-label Study of Epratuzumab in Serologically-positive Systemic Lupus Erythematosus Patients With Active Disease

Who this might be right for
Systemic Lupus Erythematosus
UCB Pharma 210
Not applicableNot Yet RecruitingNCT06919250
What this trial is testing

Physical Activity in Patients With Systemic Lupus Erythematosus

Who this might be right for
Lupus Erythematosus, Systemic
University of Oviedo 63
Testing effectiveness (Phase 2)Ended earlyNCT05879718
What this trial is testing

Learn About the Study Medicine (PF-06823859) in Adults With Active CLE or SLE With Skin Symptoms.

Who this might be right for
Lupus Erythematosus, SystemicLupus Erythematosus, Cutaneous
Pfizer 8
Testing effectiveness (Phase 2)Study completedNCT01273389
What this trial is testing

An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis

Who this might be right for
Lupus Nephritis
Janssen Research & Development, LLC 25
Large-scale testing (Phase 3)Ended earlyNCT00430677
What this trial is testing

Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis

Who this might be right for
Systemic Lupus Erythematosus
Bristol-Myers Squibb 423
Not applicableUnknownNCT04449653
What this trial is testing

Mobile Study to Measure and Predict Lupus Disease Activity Using Digital Signals

Who this might be right for
Lupus Erythematosus, SystemicLupus Erythematosus
Progentec Diagnostics, Inc. 300
Not applicableNo Longer AvailableNCT04750057
What this trial is testing

Anifrolumab Early Access Program

Who this might be right for
Systemic Lupus Erythematosus
AstraZeneca
Early research (Phase 1)Looking for participantsNCT06400537
What this trial is testing

Clinical Study of A-319 in the Treatment of Active/Refractory Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 25
Not applicableStudy completedNCT01425775
What this trial is testing

The Effect of Vitamin D Supplementation on Disease Activity Markers in Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus Erythematosus
University of Alexandria 248
Large-scale testing (Phase 3)Active Not RecruitingNCT04582136
What this trial is testing

Efficacy and Safety of Sirolimus in Active Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Chinese SLE Treatment And Research Group 146
Next Page